Table 4.
Variable | Univariate regression | Multivariate regression | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | |
Age, years | 1.019 | 1.001–1.037 | 0.036* | 0.850 | 0.236–3.056 | 0.803 |
Female gender | 2.242 | 1.302–3.860 | 0.004* | 1.470 | 0.801–2.697 | 0.213 |
Disease duration | 1.040 | 1.018–1.061 | < 0.001* | 1.240 | 0.345–4.456 | 0.742 |
Age at vitiligo onset | 0.992 | 0.974–1.009 | 0.353 | 1.188 | 0.330–4.269 | 0.792 |
Affected BSA (1–25%) | 1.684 | 1.004–2.825 | 0.048* | 0.947 | 0.508–1.763 | 0.863 |
Family history of vitiligo | 1.122 | 0.603–2.087 | 0.717 | 0.788 | 0.376–1.652 | 0.529 |
Family history of AIIDs | 2.730 | 1.559–4.781 | < 0.001* | 2.436 | 1.310–4.530 | 0.005* |
VIDA | 1.120 | 0.959–1.308 | 0.152 | 1.161 | 0.978–1.377 | 0.088 |
Constant | - | - | - | 0.085 | - | < 0.001 |
*p < 0.05
AIIDs: autoimmune and autoinflammatory diseases, VIDA: Vitiligo Disease Activity Score